Results 141 to 150 of about 20,344 (273)

Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease [PDF]

, 2016
Homare Eda, Loredana Santo, Marc N. Wein, Dorothy Hu, Diana Cirstea, Neeharika Nemani, Yu‐Tzu Tai, Sarah E Raines, Stuart Kuhstoss, Nikhil C. Munshi, Henry M. Kronenberg, Noopur Raje   +11 more
openalex   +1 more source

Osteocyte expression of caspase-3, COX-2, IL-6 and sclerostin are spatially and temporally associated following stress fracture initiation

, 2014
Andy Wu, L. J. Kidd, Nicholas Cowling, Wendy L. Kelly, Mark R. Forwood   +4 more
openalex   +2 more sources

Sclerostin-Mediated Impaired Osteogenesis by Fibroblast-Like Synoviocytes in the Particle-Induced Osteolysis Model [PDF]

, 2021
Supriya Jagga, Ashish Ranjan Sharma, Yeon Hee Lee, Ju‐Suk Nam, Sang‐Soo Lee   +4 more
openalex   +1 more source

Sclerostin [PDF]

, 2020
openaire   +1 more source

Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass

, 2014
Zachary C. Ryan, Theodore A. Craig, Meghan E. McGee‐Lawrence, Jennifer J. Westendorf, Rajiv Kumar   +4 more
openalex   +1 more source

Sclerostin levels in uremic patients: a link between bone and vascular disease [PDF]

, 2016
Annamaria Bruzzese, Antonio Lacquaniti, Valeria Cernaro, Carlo Alberto Ricciardi, Saverio Loddo, Adolfo Romeo, Gaetano Montalto, Giuseppe Costantino, Francesco La Torre, Giuseppina Pettinato, Ignazio Salamone, Carmela Aloisi, Domenico Santoro, Michele Buemi   +13 more
openalex   +1 more source

Localized sclerostin accumulation in osteocyte lacunar-canalicular system is associated with cortical bone microstructural alterations and bone fragility in db/db male mice

Frontiers in Cell and Developmental Biology
Bone fragility in type 2 diabetes mellitus (T2DM) is often characterized by impaired bone quality, despite normal or increased bone mineral density. Serum sclerostin levels are elevated in diabetes, yet its role in bone fragility is not fully understood.
Xingfan Wu, Xingfan Wu, Yuanli Ai, Yuanli Ai, Yutao He, Dan Ma, Xi Li, Xiao Huang, Rui Cheng, Bin Wang   +9 more
doaj   +1 more source

Sclerostin antibody treatment enhances rotator cuff tendon-to-bone healing in an animal model [PDF]

, 2017
Alfredson, Black, Bone, Cadet, Chouinard, Colvin, Ditsios, Galatz, Galatz, Galatz, Genin, Gimbel, Ide, Ioannis Kormpakis, Keener, Kennel, Killian, Killian, Komori, Leesa M. Galatz, Leppälä, Li, Li, Li, Lipner, Manning, McClung, Michael S. Ominsky, Nakashima, Necat Havlioglu, Ominsky, Padhi, Schwartz, Schwartz, Shivam A. Shah, Silva, Sinder, Stavros Thomopoulos, Taylor, Thomopoulos, Thomopoulos, Thomopoulos, Thomopoulos, Tian, Veverka, West   +45 more
core   +3 more sources

Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis

International Journal of Women's Health, 2015
Arti D Shah,1 Dolores Shoback,1,2 E Michael Lewiecki3,4 1Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, CA, USA; 2Endocrine Research Unit, Department of Medicine, Veterans Affairs Medical ...
Shah AD, Shoback D, Lewiecki EM
doaj  

TGF-β regulates sclerostin expression via the ECR5 enhancer

, 2011
Gabriela G. Loots, H. J. Keller, Olivier Leupin, Deepa K. Murugesh, Nicole M. Collette, Damian C. Genetos   +5 more
openalex   +2 more sources